Caspofungin treatment of Pneumocystis pneumonia during conditioning for bone marrow transplantation.
Annaloro
C
C
Ematologia I e Centro Trapianti di Midollo, Fondazione Ospedale Maggiore and Università degli Studi di Milano, Via Francesco Sforza 35, 20122 Milan, Italy. c.annaloro@policlinico.mi.it
Della Volpe
A
A
Usardi
P
P
Lambertenghi Deliliers
G
G
D000890:Anti-Infective Agents; D000935:Antifungal Agents / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000379:methods; D000077336:Caspofungin; D000075202:Contraindications; D054714:Echinocandins; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications* / Q000628:therapy; D055666:Lipopeptides; D008297:Male; D008875:Middle Aged; D010456:Peptides, Cyclic / Q000627:therapeutic use*; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D049268:Positron-Emission Tomography / Q000379:methods; D014057:Tomography, X-Ray Computed / Q000379:methods; D019172:Transplantation Conditioning / Q000379:methods; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D000890:Anti-Infective Agents; D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000077336:Caspofungin